AntivirusApplication · Vipre

CVE-2023-32175

HIGH · 7.8 CVSS v3.0 Published 2024-05-03
Fix available
A fix is available. Upgrade to 12.0.1.203 or later.
See remediation →
80/100
Remediation priority · High
Zero-click

Official description Straight from the sourceThe vendor's or NVD's own wording, published unedited. Authoritative, but often terse — it says what broke, rarely what to do.

NVD · unedited
VIPRE Antivirus Plus Link Following Local Privilege Escalation Vulnerability. This vulnerability allows local attackers to escalate privileges on affected installations of VIPRE Antivirus Plus. An attacker must first obtain the ability to execute low-privileged code on the target system in order to exploit this vulnerability. The specific flaw exists within the Anti Malware Service. By creating a symbolic link, an attacker can abuse the service to create arbitrary files. An attacker can leverage this vulnerability to escalate privileges and execute arbitrary code in the context of SYSTEM. Was ZDI-CAN-18899.

Technical summary Written by usOur analysis, written from the advisory, the CVSS vector and the affected-version data. It adds context the advisory leaves out, and never invents facts that are not in the source.

dbcve analysis · high confidence

This is a local privilege escalation vulnerability in VIPRE Antivirus Plus Anti Malware Service. The service suffers from a symbolic link following flaw that allows an attacker to create arbitrary files on the system by leveraging symlink abuse. Since the service runs as SYSTEM, an attacker with low-privileged code execution can escalate to SYSTEM-level privileges by tricking the service into creating malicious executable files via symbolic links.

MitigationApply the vendor patch for CVE-2023-32175 when available. As an interim measure, restrict write access to directories used by the Anti Malware Service and monitor for suspicious symbolic link creation. The vulnerability requires vendor code-level remediation.

Verify against the referenced sources before acting — the references below are authoritative for this CVE, this summary is not.

Affected products & versions What the vendor confirmedThe version ranges the vendor confirmed as vulnerable. If your version sits inside a range here, treat yourself as exposed until you have upgraded.

NVD · CPE data
AntivirusApplication
Affected:< 12.0.1.203

CVSS breakdown How the score is builtThe industry scoring standard. It rates how the flaw is reached, what it takes to exploit, and what an attacker gains — the score is derived from those, not the other way round.

From the vector
Attack vector
Local
Complexity
Low
Privileges
Low
User interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
High
Availability
High

CVSS:3.0/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Am I affected? How to checkSteps we derive from the advisory and the affected-version data, so you can decide whether this CVE reaches your setup. They are a guide, not a scan — your own configuration is the authority.

dbcve checks

Work through these to decide whether this CVE applies to you.

  1. Check if VIPRE Antivirus is installed
    Look for VIPRE Antivirus in Add/Remove Programs or check for installation directory (typically C:\Program Files\Vipre or C:\Program Files (x86)\Vipre)
    Affected if VIPRE Antivirus Plus is not found on the system, the product is not affected
  2. Identify installed VIPRE version
    Check the installed version by reviewing registry key HKLM\SOFTWARE\Microsoft\Windows\CurrentVersion\Uninstall\{ProductID}\DisplayVersion or look in the VIPRE installation directory for version information
    Affected if Installed version is lower than 12.0.1.203 (e.g., 12.0.0.x, 11.x, etc.)
  3. Locate the Anti Malware Service
    Open Services console (services.msc) and look for VIPRE Anti Malware service (commonly named SBAMSvc or VipreAntiMalwareService)
    Affected if The Anti Malware Service exists and is running on the system
  4. Check service executable permissions
    Right-click the service executable (found in service properties) and review Permissions tab. Verify which users have Write or Full Control permissions on the service directory
    Affected if Low-privileged users have Write permissions to directories containing the Anti Malware Service executable or its working directories
  5. Monitor for symlink creation in service directories
    Use Sysinternals Process Monitor or File Explorer to watch for .lnk or symbolic link files being created in VIPRE temp or working directories (check service properties for 'Path to executable' and working directory)
    Affected if Low-privileged users can create symbolic links in directories used by the Anti Malware Service

The system is affected if VIPRE Antivirus Plus is installed with a version lower than 12.0.1.203 AND the Anti Malware Service is running with permissive file permissions that allow low-privileged users to create symbolic links in service directories.

Generated from the published advisory. Verify against your own configuration.

Check your environment

Paste your version and any relevant configuration and it will be compared against the affected criteria above. Do not include secrets or credentials.

AI-assisted, checked against the advisory. Informational, not a guarantee.

Remediation Closing itWhat it takes to close this. Where a vendor fix exists we point at it; where none exists we say so plainly, and can build one. Effort estimates are scoped from the advisory, not from your codebase.

dbcve · scoped
Upgrade available Upgrade to 12.0.1.203 or later
Fixed in 12.0.1.203
Interim mitigation

Apply the vendor patch for CVE-2023-32175 when available. As an interim measure, restrict write access to directories used by the Anti Malware Service and monitor for suspicious symbolic link creation. The vulnerability requires vendor code-level remediation.

Recommended fix High confidence

VIPRE Antivirus Plus version 12.0.1.203

  1. Upgrade VIPRE Antivirus Plus to version 12.0.1.203 or later to resolve the symlink privilege escalation vulnerability
  2. Verify the installation by checking the installed version in the application or program settings
  3. Ensure the upgrade is tested in a non-production environment before deploying to production systems

Generated from the published advisory — verify against the referenced sources before acting.

Fix this in Antivirus Scoped from the published advisory
  • Consultation3.0 h
  • Implementation4.0 h
  • Testing3.0 h
  • Review / QA2.0 h
12.0 hours of engineering $2,130
Get the upgrade done

An estimate, not a bill — we confirm scope with you before any work starts. Need it this week? Rush from $3,408.

Scan for this in your stack

Free · runs locally
dbcve dependency scanner

Check whether your project pulls in CVE-2023-32175 — or any other known-vulnerable package — straight from your lock files. Free and open source; it runs locally and uploads nothing.

References Go to the primary sourcePrimary sources — vendor advisories, patches and trackers. Where our summary and a reference disagree, the reference wins.

Primary sources

Practitioner notes

Contributed

Peer-ranked notes from engineers who’ve handled CVE-2023-32175 in production — separate from our analysis above.

No notes yet

Be the first to add a field note for this CVE — a mitigation you’ve verified, a version caveat, or a link to a working fix. Sign in above to contribute.

What this is

A place for practitioners to share what actually worked: a mitigation you’ve tested, a configuration change, a version- or environment-specific caveat, or a link to a verified patch. The most useful notes rise to the top as peers upvote them, so the signal stays high.

What belongs here
  • Verified mitigations, workarounds, and config changes
  • Version or environment caveats, and links to real fixes
  • No weaponised exploit code, or anything meant to cause harm
  • No spam, self-promotion, credentials, or personal data